Alonzo H. Ross

TL;DR: Affinity cross-linking, metabolic labeling and immunoprecipitation, and equilibrium binding with 125I-labeled NGF revealed that this NGF receptor had the same size and binding characteristics as the receptor from human melanoma cells and rat PC12 cells.

TL;DR: The NGF receptor was visualized by immunoperoxidase staining in tissue sections of human nevi, melanomas, neurofibromas, a pheochromocytoma, and peripheral nerves as mentioned in this paper.

TL;DR: Southern blot analysis revealed no amplification or rearrangement of the ME491 gene in the human melanoma cell lines tested, including both high and low expressors of this antigen.

TL;DR: The results of antibody binding studies indicate that the epitope is closely linked to the EGF binding active site, and is common to both high- and low-affinity EGF-receptors.

TL;DR: Thirty patients with advanced colorectal carcinoma were treated with alum-precipitated polyclonal goat anti-idiotypic antibodies to monoclonal anti-CRC antibody CO17-1A in doses between 0.5 and 4 mg per injection, and all patients developed anti-anti-identical antibodies (Ab3) with binding specificities on the surfaces of cultured tumor cells similar to the specificity of Ab1.